Classification position
Valproates belong to agents with a polyvalent (combined) action. Due to the complex mechanism of action, which includes several equally important components at once, it is extremely difficult to classify this drug into a single narrow pharmacological group (for example, exclusively as GABA-affecting agents or sodium channel blockers). It is impossible to single out one predominant effect. The main representatives of this combined group are valproic acid and topiramate. In clinical practice, the drug is used both as the acid itself and in the form of its sodium salt — sodium valproate.
Mechanism of action (Triple effect)
The pharmacodynamics of the drug is based on three independent mechanisms that together provide a pronounced anticonvulsant effect:
- Sodium channel blockade. The drug directly affects neuronal membranes in the epileptogenic focus, significantly reducing their excitability and preventing the generation of pathological impulses.
- Calcium channel blockade. Valproic acid specifically blocks T-type calcium channels.
- Effect on the GABA system. The drug significantly increases the content of gamma-aminobutyric acid (the main inhibitory neurotransmitter) in brain structures. This is achieved through two parallel processes:
- Inhibition of catabolism: blockade of the GABA transaminase enzyme prevents the destruction of existing GABA.
- Stimulation of synthesis: increasing the activity of the glutamate decarboxylase enzyme accelerates the formation of new GABA molecules.
Indications and pharmacokinetics
The drug is distinguished by a broad spectrum of activity and demonstrates high clinical efficacy in virtually all known forms of epilepsy. The main indications include partial seizures, myoclonic epilepsy, as well as generalized seizures (both absence and tonic-clonic).
When administered orally, valproates demonstrate good absorption in the gastrointestinal tract. The time to reach maximum plasma concentration depends on the specific dosage form, but averages about 2 hours. The drug undergoes intensive metabolism: it is excreted from the body predominantly by the kidneys as oxidation products or in the form of conjugates with glucuronic acid (so-called glucuronides).
Safety profile
Despite its high efficacy, valproic acid therapy requires monitoring due to potential adverse effects affecting various body systems:
- Central nervous system: patients may experience drowsiness, tremor, impaired coordination (ataxia), involuntary rhythmic eye movements (nystagmus), and double vision (diplopia).
- Gastrointestinal tract: dyspeptic disorders frequently develop, including nausea, vomiting, diarrhea, and stomach pain.
- Hematopoietic system: development of anemia, decreased platelet count (thrombocytopenia), and overall impairment of blood clotting are possible.
- Allergic reactions: in most cases, they are limited to various skin manifestations.
The drug has strict contraindications. It must not be prescribed to patients with severe hepatic impairment, as well as severe pancreatic pathologies.
Briefly: answers to topical questions
What are the contraindications to the use of valproic acid?
Contraindications to the use of valproic acid include:
- Severe hepatic impairment.
- Pancreatic dysfunction.
Additionally, prescribing valproic acid is undesirable for women of childbearing potential due to the high risk of teratogenic effects.
What fetal malformations does valproic acid cause (teratogenic effect)?
Valproic acid has a pronounced teratogenic effect and can cause various severe fetal developmental anomalies. The main malformations include:
- Neural tube defects — a specific risk when taking the drug.
- General malformations — cleft lip and/or hard palate, as well as heart defects.
- Specific syndrome — includes microcephaly, growth retardation, psychomotor retardation, craniofacial anomalies, nail and distal phalanx hypoplasia, hypertelorism.
Valproate's triple hit: blocks sodium, blocks calcium (T-type), and protects GABA (inhibits transaminase, stimulates decarboxylase).
Class and exam questions
Why is valproic acid classified as a combined-action agent?
Due to its polyvalent mechanism. It is impossible to isolate a single predominant effect: it simultaneously blocks sodium and calcium channels, and also actively interferes with GABA metabolism.
How exactly does the drug increase GABA levels in the CNS?
Valproates act from two sides. They inhibit GABA transaminase, stopping neurotransmitter degradation, and simultaneously stimulate glutamate decarboxylase, accelerating GABA synthesis.
Which forms of epilepsy are treatable with valproates?
The drug has the broadest possible spectrum. It is effective in partial seizures, myoclonic epilepsy, and generalized seizures (both tonic-clonic and absence).
What else to study on this topic
- Detailed analysis of the enzymatic system of GABA synthesis and catabolism in the CNS
- The role of T-type calcium channels in the pathogenesis of epileptic seizures
- Comparative profile of valproic acid and topiramate
- Mechanisms of hepatotoxicity development during long-term administration of antiepileptic drugs
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Valproic acid" and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.